MétaCan
Menu
← Back to cohort
Record W2600507632 · doi:10.2217/ebo.13.381

EGF receptor inhibitors: patient selection and clinical outcomes

2013· other· en· W2600507632 on OpenAlexaff
Sean Warsch, Gabriel Tinoco, Stefan Glück, Kiran Avancha, Alberto J. Montero

Bibliographic record

Venuenot available
Typeother
Languageen
FieldMedicine
TopicHER2/EGFR in Cancer Research
Canadian institutionsHEC Montréal
Fundersnot available
KeywordsMiamiMedicineClinical OncologyInternal medicineBreast cancerOncologyPharmacyFamily medicineCancerLibrary science

Abstract

fetched live from OpenAlex

Breast cancer is the most common cancer in women worldwide. In 2011, an estimated 230,000 women were diagnosed with breast cancer in the USA alone, with an estimated 40,000 deaths, making it the second most common cause of cancer-related death in women [1]. The human EGF receptor 2 (HER2) is a cell-membrane tyrosine kinase receptor member of the EGF receptor family that is overexpressed in approximately 15–25% of primary human breast cancers, and is associated with poor clinical outcomes and aggressive tumor progression [2]. In a study of 965 patients with T1, node-negative breast cancer, when compared with patients with HER2-negative disease, there was a significantly worse 5-year rate of recurrence-free survival (77–94%) in patients with HER2-positive cancer [2].

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Other · Consensus signal: none
Teacher disagreement score0.003
Threshold uncertainty score0.009

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.002
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0030.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.045
GPT teacher head0.409
Teacher spread0.364 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreOther

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2013
Admission routes1
Has abstractyes

Explore more

Same topicHER2/EGFR in Cancer Research→French-language works237,207→